Donor platelet plasma components inactivate sensitive and multidrug resistant Acinetobacter baumannii isolates

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Hematology

Background:

• Acinetobacter baumannii is a resilient healthcare-associated pathogen causing diverse infections.
• Global emergence of multidrug-resistant (MDR) strains necessitates novel therapeutic strategies.
• Platelets possess antimicrobial proteins, and previous studies indicated their inhibitory effect on A. baumannii.

Purpose of the Study:

• To investigate the antimicrobial activity of platelet components against clinical MDR Acinetobacter baumannii isolates.
• To identify the specific plasma components responsible for inhibiting A. baumannii growth.

Main Methods:

• Testing the inhibitory effect of donor platelet supernatants and plasma on MDR A. baumannii isolates.
• Evaluating the correlation between antimicrobial activity and selected platelet-derived proteins.
• Identifying implicated plasma components through further analysis.

Main Results:

• Donor platelet supernatants and plasma inhibited the growth of clinical MDR A. baumannii isolates.
• The observed growth inhibition was not linked to specific platelet-derived antimicrobial proteins.
• Plasma components, specifically complement and alpha-2 macroglobulin, were implicated in the inhibitory activity.

Conclusions:

• Platelet-derived factors, particularly plasma components like complement and alpha-2 macroglobulin, exhibit antimicrobial activity against MDR Acinetobacter baumannii.
• This finding suggests potential alternative therapeutic avenues for A. baumannii infections.
• Further research is warranted to elucidate the precise mechanisms and therapeutic potential.